Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1Terminated 1Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Neoplasms 4Carcinoma, Non-Small-Cell Lung 3Breast Neoplasms 3Prostatic Neoplasms 2Delirium 2Thrombocytopenia 1Stomatitis 1Pleural Effusion 1Pelvic Neoplasms 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Pancreatic Neoplasms 1Pancreatic Cyst 1Ovarian Neoplasms 1Otolaryngeal Cancer 1Metabolic Diseases 1Lung Neoplasms 1Leukemia, Myeloid, Acute 1Kidney Neoplasms 1Hemostatic Disorders 1Head and Neck Neoplasms 1Emergence Delirium 1Chemotherapy-Related Cognitive Impairment 1Anemia, Aplastic 1

Interventions

hydrated silica gel-based toothpaste 1cobiprostone 1clazakizumab 1aluminum hydroxide, magnesium hydroxide, drug combination 1Zinc Sulfate 1Zinc 1Tomography, Optical Coherence 1Surveys and Questionnaires 1Standard of Care 1Spectrometry, Fluorescence 1Sodium Bicarbonate 1Saliva, Artificial 1Saline Solution 1Radiation 1Mannitol 1Lidocaine 1Etanercept 1Drug Therapy 1Diphenhydramine 1Dental Prophylaxis 1Biotene 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Stomatitis × Saline Solution × Clear all
NCT01403064 2021-05-11

Safety and Efficacy of ALD518 for Reducing Oral Mucositis in Head and Neck Cancer Subjects

CSL Behring

Phase 2 Terminated
76 enrolled 25 charts
Head & Neck

Head and Neck Neoplasms, Stomatitis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡